Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Lehrich

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Neurology|October 1, 1990
Multiple sclerosis sibling pairs: clustered onset and familial predispositionT H Doolittle, R H Myers, J R Lehrich, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Neurology|October 1, 1990
Multiple sclerosis sibling pairs: clustered onset and familial predispositionT H Doolittle, R H Myers, J R Lehrich, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Pageof 2